| |||||||||
Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Donating Investigator Paul Dawson, Wake Forest University Sch of Medicine Description
Mice that are homozygous for the targeted mutation are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. Male pups tend to be smaller in size than female pups prior to weaning. No gene product (mRNA or protein) is detected by Northern or Western blot analysis of the distal small intestine. Ileal brush border membrane vesicles isolated from homozygotes do not exhibit sodium ion dependent taurocholate uptake, indicating a loss of sodium bile acid cotransporter activity. Total plasma cholesterol levels are slightly higher than normal. Total bile acid pool size is reduced approximately 80% in homozygous mutants, although intestinal lipid absorption is reduced by only about 10%. Bile acid functional turnover rate (daily fecal bile acid excretion/pool size) is elevated 150 fold in male mutants and 75 fold in female mutants. Fecal bile acid excretion is increased 24 fold in male mutants and 11 fold in female mutants. Bile acid composition is abnormal. Fecal lipid excretion of total fat, fatty acid and neutral sterols is increased approximately 4 fold. Cholesterol absorption in the intestine is reduced by 26% in male mutants and 15% in female mutants. Cholesterol 7 alpha hydroxylase activity is increased by 2.7 fold in males and 5.2 fold in females homozygous for the mutant allele. Hepatic bile acid synthesis is increased and total hepatic cholesterol and cholesteryl ester levels are reduced. This mutant mouse strain may be useful in studies of cholesterol, lipoprotein and bile acid metabolism, and primary bile acid malabsorption.Development
A targeting vector containing neomycin resistance and herpes simplex virus thymidine kinase genes was used to disrupt exon 3 and the splice acceptor site of exon 4. The construct was electroporated into 129P2/OlaHsd derived E14TG2a embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6J blastocysts. The resulting chimeric animals were crossed to 129S6/SvEvTac mice. Heterozygotes were bred to generate homozygotes.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 002448 129S1/SvImJ | ||
| Appropriate controls depend on the nature of the experiment. Wildtype mice from the colony or 129S1/SvImJ mice (Stock No. 002448) may be included among the controls considered. | ||
| Considerations for Choosing Controls | ||
Genetic Quality Control Annual Report
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Slc10a2tm1Pda/Slc10a2tm1Pda
either: (involves: 129P2/OlaHsd * 129S6/SvEv) or (involves: 129P2/OlaHsd * C57BL/6J)
- digestive/alimentary phenotype
- abnormal nutrient absorption (MGI Ref ID J:85312)
- fecal bile acid excretion increased 24X in males and 11X in females
- decrease in intestinal absorption of lipid from 98% to 95% in females and 93% in males
- 26% reduction in cholesterol absorption in males and 15% reduction in females
- steatorrhea (MGI Ref ID J:85312)
- 4X increase in total fat, fatty acid, and neutral sterol excretion
- amount of fat excreted is small however
- growth/size phenotype
- decreased body weight (MGI Ref ID J:85312)
- small growth deficit in males but not females prior to weaning
- 20% decrease in body weight was transitory
- homeostasis/metabolism phenotype
- abnormal bile salt homeostasis (MGI Ref ID J:85312)
- total bile acid pool decreased 83% in males and 80% in females
- abnormal bile salt level (MGI Ref ID J:85312)
- bile acid pool composition is altered, taurocholate predominates
- abnormal lipid homeostasis (MGI Ref ID J:85312)
- increased circulating cholesterol level (MGI Ref ID J:85312)
- small but signifacant increase seen
- liver/biliary system phenotype
- abnormal bile composition (MGI Ref ID J:85312)
- bile acid pool composition is altered, taurocholate predominates
- abnormal liver physiology (MGI Ref ID J:85312)
- huge elevation in bile acid fractional turnover rate, 150% in males and 75% in females
- cholesteryl ester levels in liver are significantly lower
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Slc10a2tm1Pda/Slc10a2tm1Pda
either: B6.129P2-Slc10a2tm1Pda or (involves: 129P2/OlaHsd * C57BL/6J)
- homeostasis/metabolism phenotype
- abnormal bile salt homeostasis (MGI Ref ID J:132778)
- in everted gut sac experiments, mucosal-to-serosal transport of taurocholate is reduced, indicating impaired intestinal bile acid transport
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Slc10a2tm1Pda related
Cardiovascular Research
Hypercholesterolemia
Metabolism Research
Lipid Metabolism
| Allele Symbol | Slc10a2tm1Pda | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Paul A Dawson | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Asbt-; Slc10a2-/-; | ||
| Mutation Made By | Paul Dawson, Wake Forest University Sch of Medicine | ||
| Strain of Origin | 129P2/OlaHsd | ||
| ES Cell Line Name | E14TG2a | ||
| ES Cell Line Strain | 129P2/OlaHsd | ||
| Gene Symbol and Name | Slc10a2, solute carrier family 10, member 2 | ||
| Chromosome | 8 | ||
| Gene Common Name(s) | ASBT; ISBAT; ISBT; NTCP2; | ||
| Molecular Note | A region of the gene extending from intron 2 through to the splice acceptor site of exon 4 was replaced with a neomycin resistance cassette. Absence of gene products was confirmed by Northern blots and by immunoblots. [MGI Ref ID J:85312] | ||
This strain will not have a genotyping protocol or one is not currently available.
Helpful Links
Optimizing PCR Protocols
Dawson PA; Haywood J; Craddock AL; Wilson M; Tietjen M; Kluckman K; Maeda N; Parks JS. 2003. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 278(36):33920-7. [PubMed: 12819193] [MGI Ref ID J:85312]
Slc10a2tm1Pda relatedDawson PA; Hubbert M; Haywood J; Craddock AL; Zerangue N; Christian WV; Ballatori N. 2005. The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem 280(8):6960-8. [PubMed: 15563450] [MGI Ref ID J:106032]
Jung D; Inagaki T; Gerard RD; Dawson PA; Kliewer SA; Mangelsdorf DJ; Moschetta A. 2007. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. J Lipid Res 48(12):2693-700. [PubMed: 17823457] [MGI Ref ID J:129925]
Rao A; Haywood J; Craddock AL; Belinsky MG; Kruh GD; Dawson PA. 2008. The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis. Proc Natl Acad Sci U S A 105(10):3891-6. [PubMed: 18292224] [MGI Ref ID J:132778]
Colony Maintenance
Breeding & Husbandry This strain is maintained as a heterozygote. Male pups tend to be smaller in size than female pups prior to weaning. Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00 Cryopreserved Embryos Fee $1600.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00 Cryopreserved Embryos Fee $2080.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 002448 129S1/SvImJ | ||
| Appropriate controls depend on the nature of the experiment. Wildtype mice from the colony or 129S1/SvImJ mice (Stock No. 002448) may be included among the controls considered. | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.